{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:25:07Z","timestamp":1775809507097,"version":"3.50.1"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K16921"],"award-info":[{"award-number":["18K16921"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229231","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T18:27:55Z","timestamp":1582568875000},"page":"e0229231","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy"],"prefix":"10.1371","volume":"15","author":[{"given":"Kikushima","family":"Wataru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2894-0454","authenticated-orcid":true,"given":"Yoichi","family":"Sakurada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"issue":"1","key":"pone.0229231.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy (IPCV)","volume":"10","author":"LA Yannuzzi","year":"1990","journal-title":"Retina"},{"issue":"2","key":"pone.0229231.ref002","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","article-title":"Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy","volume":"15","author":"RF Spaide","year":"1995","journal-title":"Retina"},{"issue":"4","key":"pone.0229231.ref003","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0002-9394(03)01147-4","article-title":"Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy","volume":"137","author":"K Nishijima","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"pone.0229231.ref004","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.ophtha.2003.12.056","article-title":"Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series","volume":"111","author":"WM Chan","year":"2004","journal-title":"Ophthalmology"},{"issue":"1","key":"pone.0229231.ref005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/bjo.2007.122283","article-title":"Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy","volume":"92","author":"F Gomi","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"pone.0229231.ref006","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ajo.2009.12.038","article-title":"Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy","volume":"149","author":"T Sato","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"pone.0229231.ref007","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","article-title":"Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial","volume":"135","author":"A Koh","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"pone.0229231.ref008","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1089\/jop.2013.0044","article-title":"Two-year results of photodynamic therapy with or without intravitreal ranibizumab for polypoidal choroidal vasculopathy","volume":"29","author":"Y Sakurada","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"pone.0229231.ref009","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00417-016-3467-y","article-title":"Comparison of initial treatment between 3-monthly intravitreal aflibercept monotherapy and combined photodynamic therapy with single intravitreal aflibercept for polypoidal choroidal vasculopathy","volume":"255","author":"W Kikushima","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"pone.0229231.ref010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s10384-018-0636-z","article-title":"The 24-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy","volume":"63","author":"S Nakai","year":"2019","journal-title":"Jpn J Ophthalmol"},{"issue":"8","key":"pone.0229231.ref011","doi-asserted-by":"crossref","first-page":"e765","DOI":"10.1111\/aos.13130","article-title":"Three-year visual outcomes of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy","volume":"94","author":"T Sakai","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"pone.0229231.ref012","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ajo.2010.02.008","article-title":"Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy","volume":"150","author":"F Gomi","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"pone.0229231.ref013","article-title":"Five-year visual outcomes after anti-VEGF therapy with or without photodynamic therapy for polypoidal choroidal vasculopathy","author":"M Miyata","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"pone.0229231.ref014","doi-asserted-by":"crossref","first-page":"e0149978","DOI":"10.1371\/journal.pone.0149978","article-title":"Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration","volume":"11","author":"Y Sakurada","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"pone.0229231.ref015","doi-asserted-by":"crossref","first-page":"11906","DOI":"10.1038\/s41598-019-48494-6","article-title":"Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration","volume":"9","author":"Y Fukuda","year":"2019","journal-title":"Sci Rep"},{"issue":"8","key":"pone.0229231.ref016","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.4103\/ijo.IJO_1222_17","article-title":"Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy","volume":"66","author":"P Jain","year":"2018","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"pone.0229231.ref017","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12886-019-1245-4","article-title":"Five-year real-world outcomes of anti-vascular endothelial growth factor monotherapy versus combination therapy for polypoidal choroidal vasculopathy in a Chinese population: a retrospective study","volume":"19","author":"J Yang","year":"2019","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"pone.0229231.ref018","doi-asserted-by":"crossref","first-page":"16461","DOI":"10.1038\/s41598-017-16476-1","article-title":"Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy","volume":"7","author":"W Kikushima","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"pone.0229231.ref019","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ajo.2011.01.002","article-title":"Association of lesion size and visual prognosis to polypoidal choroidal vasculopathy","volume":"151","author":"A Tsujikawa","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"pone.0229231.ref020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000360308","article-title":"Comparison of the outcomes of photodynamic therapy between two angiographic subtypes of polypoidal choroidal vasculopathy","volume":"232","author":"S Honda","year":"2014","journal-title":"Ophthalmologica"},{"issue":"5","key":"pone.0229231.ref021","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ajo.2012.03.051","article-title":"Photodynamic therapy with or without intravitreal bevacizumab for polypoidal choroidal vasculopathy: two years of follow-up","volume":"154","author":"YA Lee","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"pone.0229231.ref022","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1097\/IAE.0000000000001427","article-title":"Choroidal Thickness as a Prognostic Factor of Photodynamic Therapy with Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy","volume":"37","author":"Y Sakurada","year":"2017","journal-title":"Retina"},{"issue":"3","key":"pone.0229231.ref023","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ajo.2013.03.041","article-title":"Choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy in recurrent polypoidal choroidal vasculopathy","volume":"156","author":"I Maruko","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"pone.0229231.ref024","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/IAE.0b013e3181af0d72","article-title":"Angiographic lesion size associated with LOC387715 A69S genotype in subfoveal polypoidal choroidal vasculopathy","volume":"29","author":"Y Sakurada","year":"2009","journal-title":"Retina"},{"issue":"7","key":"pone.0229231.ref025","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ophtha.2010.12.010","article-title":"Role of complement factor H I62V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy","volume":"118","author":"Y Sakurada","year":"2011","journal-title":"Ophthalmology"},{"issue":"8","key":"pone.0229231.ref026","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/IAE.0000000000000964","article-title":"Genetic Factors Associated with Choroidal Vascular Hyperpermeability and Subfoveal Choroidal Thickness in Polypoidal Choroidal Vasculopathy","volume":"36","author":"S Yoneyama","year":"2016","journal-title":"Retina"},{"issue":"10","key":"pone.0229231.ref027","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1097\/IAE.0b013e3181e587e3","article-title":"Association of LOC387715 A69S genotype with visual prognosis after photodynamic therapy for polypoidal choroidal vasculopathy","volume":"30","author":"Y Sakurada","year":"2010","journal-title":"Retina"},{"key":"pone.0229231.ref028","doi-asserted-by":"crossref","first-page":"44020","DOI":"10.1038\/srep44020","article-title":"Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration","volume":"7","author":"W Kikushima","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0229231.ref029","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1038\/s41598-017-09632-0","article-title":"A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration","volume":"7","author":"K Yamashiro","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0229231.ref030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000480439","article-title":"Retreatment of Exudative Age-Related Macular Degeneration after Loading 3-Monthly Intravitreal Ranibizumab","volume":"239","author":"A Sugiyama","year":"2018","journal-title":"Ophthalmologica"},{"key":"pone.0229231.ref031","article-title":"Association of an age-related maculopathy susceptibility 2 gene variant with the 12-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy","author":"S Nakai","year":"2019","journal-title":"Jpn J Ophthalmol"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0230505","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T14:18:22Z","timestamp":1695824302000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229231"}},"subtitle":[],"editor":[{"given":"Michael R","family":"Hamblin","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229231","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0230505","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,24]]}}}